QuidelOrtho Corp (NAS:QDEL)
$ 44.18 2.07 (4.92%) Market Cap: 2.96 Bil Enterprise Value: 5.49 Bil PE Ratio: 0 PB Ratio: 0.89 GF Score: 82/100

QuidelOrtho Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 06:55PM GMT
Release Date Price: $73.72 (-1.07%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Good afternoon. My name is Tejas Savant, and I'm the Life Science Tools and Diagnostics Analyst here at Morgan Stanley. Before we begin, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep. So it's my pleasure this afternoon to host QuidelOrtho and speaking on behalf of the company, we have Doug Bryant, Chairman and CEO; and Joe Busky, CFO. Thank you both for joining us today.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So Doug, maybe just to set the stage, it's been about 5 quarters since the 2 companies came together. Can you just talk about your key accomplishments over the last 12 months or so? And what are you most excited about as you look to 2024?

Douglas C. Bryant
QuidelOrtho Corporation - President, CEO & Director

Yes, thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot